Peptides Weekly

Peptides Weekly Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding. What You Need to Know: Six unapproved peptides can be compounded in US pharmacies without an FDA safety finding. Health and Human Services has said it will not enforce against licensed compounders of that set, even though the FDA's drug center opposed the idea. ... Sources: bioxconomy.com · demokratis.co.id · finance.yahoo.com · europepmc.org · bioprocessintl.com · boxinginsider.com AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin. What You Need to Know: A Victorian coroner has linked actor Richard Norton's cardiac arrest to two prescribed but unapproved peptides, CJC-1295 and ipamorelin, and asked Australia's regulator to reconsider whether doctors should be able to prescribe them. ... Sources: theguardian.com · abc.net.au · bbc.com · newsable.asianetnews.com · safemedicines.org · news.ssbcrack.com · statnews.com · firstwordpharma.com AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls. What You Need to Know: In a cross-sectional comparison presented at a dermatology congress, thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of people who had never taken the drugs. A separate surgical-record analysis linked the same drug class to slightly lower odds of combined heart and infection problems after planned operations. ... Sources: labroots.com · yahoo.com · safemedicines.org · statnews.com · news-medical.net · eewmagazineonline.com · netimes.com.au AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 📬 Get the sources and notes by email, free: join the newsletter 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. What You Need to Know: Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. The link was seen in adults with type 2 diabetes and does not prove the drugs injured the optic nerve. ... Sources: ua.news · sciencedaily.com · biospace.com · medicaldaily.com · bipc.com · komu.com AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. What You Need to Know: Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. Political Wire, quoting The Washington Post, describes a drafting process for previously restricted peptides, not a completed approval and not a patient trial. ... Sources: washingtonpost.com · stocktwits.com · ascopost.com · amp.sacbee.com · foodnavigator.com AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. If this episode was useful, a rating or a short review on Apple Podcasts or Spotify is how the next listener finds the show — and following it in your app means the next episode is there when you are. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Nail detachment was over four times more common in people using GLP-1 drugs. What You Need to Know: A controlled study found nail detachment more than four times as often among people using GLP-1 drugs. The same week brought a muscle-loss trial beside semaglutide, a randomized look at how semaglutide meets the kidney, and two reminders that a population trend and a protein-design paper are not treatment results. ... Sources: medicalxpress.com · reuters.com · nature.com · t.co AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study. What You Need to Know: A retrospective analysis found nutritional deficiencies in almost 17 percent of children prescribed GLP-1 receptor agonists for weight loss or diabetes. The finding comes from claims data and highlights a measurable gap in monitoring for younger patients. ... Sources: sciencedaily.com · yaledailynews.com · euractiv.com · velo.outsideonline.com · sciencedirect.com · europepmc.org AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.

Peptides Weekly Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were released this week. What You Need to Know: Novo Nordisk reported new phase 3 data on an amylin-based candidate. A pair of randomized trials found oral semaglutide did not slow progression in mild Alzheimer’s disease. ... AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production. 📝 Full show notes, transcript & sources: read the episode page 🌐 Part of the Nerra Network — explore every show at nerranetwork.com.